Merger upside masks sharp Q1 decline; execution risk is material

Hubtown's Q1 tells two stories at once. Operationally, it was a collapse: revenue down 17% YoY to ₹155.6 Cr, profit down 68% YoY to ₹26.6 Cr. Structurally, it advances a long thesis: ₹11,583 Cr of pre-sales is already collected as cash and awaits project handovers (OCs) to be recognized as revenue, underpinning multi-quarter earnings visibility. The market has chosen which story to believe. The stock is down 45% from its all-time high of ₹339, FII ownership has collapsed from 3.69% to 1.48% year-over-year — institutions are exiting — and the post-result selloff actually deepened from day 1 (−0.98%) to day 5 (−6.18%). That fade is the street's verdict: the long-term thesis is acknowledged, but near-term execution risk is material, and repricing is underway.

Revenue fell 17% YoY to ₹155.6 Cr. Management's defense: only three projects received their occupancy certificates (OCs) in Q1, limiting revenue recognition under RERA rules. Cash was collected long ago — ₹8,352 Cr cumulatively on ₹14,835 Cr of cumulative pre-sales — but RERA requires handover before revenue is recorded. This timing explanation is mechanically sound, but it doesn't change the headline: Q1 delivery was weak.

Pre-sales tell a softer story still. Q1 pre-sales were ₹535 Cr, flat year-over-year. Management claimed 'strong luxury demand' and robust walk-ins throughout Q1 (normally a seasonal trough), but the numbers haven't caught up. Collections were ₹320 Cr — a 3.2x ratio to pre-sales — but this reflects drawdown of money already received in prior years, not new customer conversion. In aggregate, Q1 shows cash discipline (positive for refinancing) but not yet sales traction.

Of ₹14,835 Cr in cumulative pre-sales, Hubtown has recognized only ₹3,252 Cr as revenue. But it has already collected ₹8,352 Cr in cash. The math: ₹8,352 Cr − ₹3,252 Cr = ₹5,100 Cr already collected but not yet handed over. Add the ₹6,483 Cr still to be collected on future handovers, and the total contracted revenue still awaiting OC/handover is ₹11,583 Cr. This is the real story of the quarter — it's not that sales are weak, it's that recognition is lumpy. Rising City Phase 1 (Ghatkopar), 25 South towers 2 & 3 (Prabhadevi), Premiere towers (Andheri West), Royale (Ahmedabad), and Northstar (Mehsana) all have OCs expected in Q2–Q4 FY27. When those handovers land, ₹2,000+ Cr of this embedded pipeline will be recognized, vindicating the embedded-revenue thesis and pushing earnings sharply higher.

Hubtown is caught in a classic tension between long-term structural strength and near-term execution risk. The long-term case is sound: ₹11,583 Cr of embedded contracted revenue is real and will be recognized over the next 2–4 quarters; the 34-MSF post-merger portfolio is transformational; luxury micro-markets (South Mumbai, Bandra, Prabhadevi) have structural pricing power and sticky HNI demand. But the near-term path is narrow and risky. Q1 revenue and profit both missed badly (−17% and −68% YoY), pre-sales are flat despite a 'strong demand' narrative, and the full-year ₹6,000 Cr pre-sales guidance is 91% dependent on Q3–Q4 launches that are not yet finalized. Most damning, the street has lost patience: the stock is down 45% from its peak, FII ownership has halved, and the post-result selloff accelerated through day 5.

This is not a simple value trap. Rather, it's an execution binary. If management closes H2 launches on time, NCLT approvals hold, OCs land in Q2–Q3, and debt refinancing closes by year-end, the stock is likely oversold and will re-rate 30–50% higher. But if any pillar cracks — if 25 Estates approvals delay, if NCLT hits roadblocks, if pre-sales momentum stays flat into Q2–Q3, or if refinancing remains unsigned — then the embedded pipeline thesis is pushed into FY28, earnings remain lumpy, and the stock could easily revisit the 52-week low of ₹168.

The number to track is pre-sales in Q2–Q3 FY27. If combined Q2–Q3 pre-sales exceed ₹3,000 Cr (showing momentum into the big H2 launches), the bear case is fading and the stock has room to recover. If they stay under ₹2,500 Cr, the ₹6,000 Cr full-year guidance is likely to miss by ₹1,000+ Cr, and the stock will stay under pressure. That one metric tells you whether the street's 45% repricing is overdone (opportunity) or justified (trap).